Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas
Article in Urologic Oncology Seminars and Original Investigations (April 2019)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre.
Article in International Journal of Hematology-Oncology and Stem Cell Research (July 2018)
Efficacy of targeted therapy for advanced renal cell carcinoma: A systematic review and meta-analysis of randomized controlled trials
Article in International braz j urol (April 2018)